TransCon hGH (lonapegsomatropin), an investigational GHD therapy administered once weekly

Our investigational long-acting growth hormone prodrug releases somatropin (rhGH or hGH) with once-weekly administration. Marketing applications have been submitted in the United States and Europe for pediatric growth hormone deficiency (GHD).

We are passionate about patients and science

We are a dynamic place to grow and learn with a unique global culture and entrepreneurial spirit.

You are about to access www.ascendispharma.com. Click below if you wish to proceed.